Evidence map›Paper›PMID 25912675›Full record

ArticleMolecular and cellular biochemistry2015

Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells.

R Barzalobre-Gerónimo, Barzalobre-Gerónimo Raúl, L A Flores-López, Flores-López Luis Antonio, L A Baiza-Gutman, Baiza-Gutman Luis Arturo, M Cruz, Cruz Miguel, R García-Macedo, García-Macedo Rebeca and 8 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. The mitochondrial enzyme pyruvate carboxylase restricts pancreatic β-cell senescence by blocking p53 activation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Review
  4. Article
  5. Tumour protein 53 is linked with type 2 diabetes mellitus.The Indian journal of medical research · 2017
    Article
  6. Is p53 Involved in Tissue-Specific Insulin Resistance Formation?Oxidative medicine and cellular longevity · 2017
    Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

R Barzalobre-GerónimoUnidad de Investigación Médica en Bioquímica, HE, Centro Médico Nacional Siglo XXI, IMSS, Av Cuauhtémoc 330, Col Doctores, Del. Cuauhtémoc, C.P. 06720, Mexico, DF, Mexico.
Barzalobre-Gerónimo Raúl
L A Flores-López
Flores-López Luis Antonio
L A Baiza-Gutman
Baiza-Gutman Luis Arturo
M Cruz
Cruz Miguel
R García-Macedo
García-Macedo Rebeca
A Ávalos-Rodríguez
Ávalos-Rodríguez Alejandro
A Contreras-Ramos
Contreras-Ramos Alejandra
A Díaz-Flores
Díaz-Flores Margarita
C Ortega-Camarillo
Ortega-Camarillo Clara
Centro Medico Nacional Siglo XXI · MXHospital Infantil de México Federico Gómez · MXUniversidad Autónoma Metropolitana · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The apoptosis of β cells induced by hyperglycemia has been associated with p53 mobilization to mitochondria and p53 phosphorylation. Murine double minute 2 (Mdm2) induces the degradation of p53 and thereby protects cells from apoptosis. We studied the effect of glucose at high concentration on the ability of Mdm2 to ubiquitinate p53 and promote its degradation. RINm5F cells were grown in RPMI-1640 medium with 5 or 30 mM glucose for varying periods of time. After this treatment, the expression of Mdm2 was measured using real-time PCR. The phosphorylation of Mdm2 at Ser166, p53 at Ser15, and the kinases Akt and ATM were measured by Western blotting. The formation of the p53-Mdm2 complex and p53 ubiquitination was assessed by p53 immunoprecipitation and immunofluorescence. Our results showed that high glucose reduced Mdm2 mRNA expression and protein concentration and increased Mdm2 and Akt phosphorylation, albeit with slower kinetics for Akt. It also promoted p53-Mdm2 complex formation, whereas p53 ubiquitination was suppressed. Furthermore, phosphorylation of both p53 Ser15 and ATM was increased in the presence of 30 mM glucose. These data indicate that high concentration glucose decrease the mRNA expression and cytosolic concentration of Mdm2. However, although the increase in glucose promoted the phosphorylation of Mdm2, it also decreased p53 ubiquitination, thus avoiding p53 degradation. In hyperglycemic conditions, such as diabetes mellitus, the reduction of pancreatic β cells mass is favored by stabilization of p53 in association with low p53 ubiquitination and reduced expression of Mdm2.

Indexed as

AnimalsApoptosisCell Line, TumorGlucoseHyperglycemiaInsulin-Secreting CellsMitochondriaPhosphorylationProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mdm2RatsRNA, MessengerTumor Suppressor Protein p53UbiquitinationGlucoseMdm2 protein, ratProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mdm2RNA, MessengerTumor Suppressor Protein p53

Identifiers

PMID25912675
OpenAlexW2056479446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.